Contineum Therapeutics Class A Common Stock Statistics Share Statistics Contineum Therapeutics Class A Common Stock has 25.87M
shares outstanding. The number of shares has increased by 0.58%
in one year.
Shares Outstanding 25.87M Shares Change (YoY) 0.58% Shares Change (QoQ) 0% Owned by Institutions (%) 52.44% Shares Floating 18.24M Failed to Deliver (FTD) Shares 563 FTD / Avg. Volume 0.26%
Short Selling Information The latest short interest is 439.14K, so 1.7% of the outstanding
shares have been sold short.
Short Interest 439.14K Short % of Shares Out 1.7% Short % of Float 2.59% Short Ratio (days to cover) 2.9
Valuation Ratios The PE ratio is -6.71 and the forward
PE ratio is -2.43.
Contineum Therapeutics Class A Common Stock's PEG ratio is
0.02.
PE Ratio -6.71 Forward PE -2.43 PS Ratio 0 Forward PS n/a PB Ratio 1.43 P/FCF Ratio -8.5 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Contineum Therapeutics Class A Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 20.69,
with a Debt / Equity ratio of 0.03.
Current Ratio 20.69 Quick Ratio 20.69 Debt / Equity 0.03 Debt / EBITDA -0.15 Debt / FCF -0.19 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.03M Employee Count 41 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -62.88% in the
last 52 weeks. The beta is 1.05, so Contineum Therapeutics Class A Common Stock's
price volatility has been higher than the market average.
Beta 1.05 52-Week Price Change -62.88% 50-Day Moving Average 4.67 200-Day Moving Average 8.65 Relative Strength Index (RSI) 65.61 Average Volume (20 Days) 219,804
Income Statement
Revenue n/a Gross Profit n/a Operating Income -50.89M Net Income -42.26M EBITDA -42M EBIT -42.26M Earnings Per Share (EPS) -2.18
Full Income Statement Balance Sheet The company has 21.94M in cash and 6.26M in
debt, giving a net cash position of 15.68M.
Cash & Cash Equivalents 21.94M Total Debt 6.26M Net Cash 15.68M Retained Earnings -117.4M Total Assets 182.89M Working Capital 169.63M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -32.84M
and capital expenditures -514K, giving a free cash flow of -33.36M.
Operating Cash Flow -32.84M Capital Expenditures -514K Free Cash Flow -33.36M FCF Per Share -1.72
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
